BAP1 and malignant pleural mesothelioma: Baseline and treatment characteristics of patients with malignant pleural mesothelioma in Group A (BAP1 inactivating mutation/copy number loss, n-8) and Group B (without a BAP1 alteration/not tested, n-37).